Published Application/Species/Sample/Dilution | Reference |
---|
- flow cytometry; human; loading ...; fig 3c
| Leylek R, Alcántara Hernández M, Lanzar Z, Lüdtke A, Perez O, Reizis B, et al. Integrated Cross-Species Analysis Identifies a Conserved Transitional Dendritic Cell Population. Cell Rep. 2019;29:3736-3750.e8 pubmed publisher
|
| Kaplonek P, Cizmeci D, Kwatra G, Izu A, Lee J, Bertera H, et al. ChAdOx1 nCoV-19 (AZD1222) vaccine-induced Fc receptor binding tracks with differential susceptibility to COVID-19. Nat Immunol. 2023;24:1161-1172 pubmed publisher
|
| Bartsch Y, Cizmeci D, Kang J, Gao H, Shi W, Chandrashekar A, et al. Selective SARS-CoV2 BA.2 escape of antibody Fc/Fc-receptor interactions. iScience. 2023;26:106582 pubmed publisher
|
| Adams L, Leist S, Dinnon K, West A, Gully K, Anderson E, et al. Fc-mediated pan-sarbecovirus protection after alphavirus vector vaccination. Cell Rep. 2023;42:112326 pubmed publisher
|
| Roy V, Jung W, Linde C, Coates E, Ledgerwood J, Costner P, et al. Differences in HPV-specific antibody Fc-effector functions following Gardasil® and Cervarix® vaccination. NPJ Vaccines. 2023;8:39 pubmed publisher
|
| Boudreau C, Burke J, Roederer A, Gorman M, Mundle S, Lingwood D, et al. Pre-existing Fc profiles shape the evolution of neutralizing antibody breadth following influenza vaccination. Cell Rep Med. 2023;4:100975 pubmed publisher
|
| Loos C, Coccia M, Didierlaurent A, Essaghir A, Fallon J, Lauffenburger D, et al. Systems serology-based comparison of antibody effector functions induced by adjuvanted vaccines to guide vaccine design. NPJ Vaccines. 2023;8:34 pubmed publisher
|
| Rohwedder I, Wackerbarth L, Heinig K, Ballweg A, Altst xe4 tter J, Ripphahn M, et al. A20 and the noncanonical NF-κB pathway are key regulators of neutrophil recruitment during fetal ontogeny. JCI Insight. 2023;8: pubmed publisher
|
| Herman J, Wang C, Burke J, Zur Y, Compere H, Kang J, et al. Nucleocapsid-specific antibody function is associated with therapeutic benefits from COVID-19 convalescent plasma therapy. Cell Rep Med. 2022;3:100811 pubmed publisher
|
| Bates T, Lu P, Kang Y, Schoen D, Thornton M, McBride S, et al. BNT162b2-induced neutralizing and non-neutralizing antibody functions against SARS-CoV-2 diminish with age. Cell Rep. 2022;41:111544 pubmed publisher
|
| LaSalle T, Gonye A, Freeman S, Kaplonek P, Gushterova I, Kays K, et al. Longitudinal characterization of circulating neutrophils uncovers phenotypes associated with severity in hospitalized COVID-19 patients. Cell Rep Med. 2022;3:100779 pubmed publisher
|
| Dolatshahi S, Butler A, Pou C, Henckel E, Bernhardsson A, Gustafsson A, et al. Selective transfer of maternal antibodies in preterm and fullterm children. Sci Rep. 2022;12:14937 pubmed publisher
|
| Bernshtein B, Ndungo E, Cizmeci D, Xu P, Kov xe1 x10d P, Kelly M, et al. Systems approach to define humoral correlates of immunity to Shigella. Cell Rep. 2022;40:111216 pubmed publisher
|
| Davies L, Cizmeci D, Guo W, Luedemann C, Alexander Parrish R, Grant L, et al. Polysaccharide and conjugate vaccines to Streptococcus pneumoniae generate distinct humoral responses. Sci Transl Med. 2022;14:eabm4065 pubmed publisher
|
| Bartsch Y, St Denis K, Kaplonek P, Kang J, Lam E, Burns M, et al. SARS-CoV-2 mRNA vaccination elicits robust antibody responses in children. Sci Transl Med. 2022;14:eabn9237 pubmed publisher
|
| Malherbe D, Domi A, Hauser M, Atyeo C, Fischinger S, Hyde M, et al. A single immunization with a modified vaccinia Ankara vectored vaccine producing Sudan virus-like particles protects from lethal infection. NPJ Vaccines. 2022;7:83 pubmed publisher
|
| Atyeo C, Shook L, Brigida S, De Guzman R, Demidkin S, Muir C, et al. Maternal immune response and placental antibody transfer after COVID-19 vaccination across trimester and platforms. Nat Commun. 2022;13:3571 pubmed publisher
|
| House R, Broge T, Suscovich T, Snow D, Tomic M, Nonet G, et al. Evaluation of strategies to modify Anti-SARS-CoV-2 monoclonal antibodies for optimal functionality as therapeutics. PLoS ONE. 2022;17:e0267796 pubmed publisher
|
| Spatola M, Loos C, Cizmeci D, Webb N, Gorman M, Rossignol E, et al. Functional Compartmentalization of Antibodies in the Central Nervous System During Chronic HIV Infection. J Infect Dis. 2022;226:738-750 pubmed publisher
|
| Zelter T, Strahilevitz J, Simantov K, Yajuk O, Adams Y, Ramstedt Jensen A, et al. Neutrophils impose strong immune pressure against PfEMP1 variants implicated in cerebral malaria. EMBO Rep. 2022;23:e53641 pubmed publisher
|
| Schloss M, Hulsmans M, Rohde D, Lee I, Severe N, Foy B, et al. B lymphocyte-derived acetylcholine limits steady-state and emergency hematopoiesis. Nat Immunol. 2022;23:605-618 pubmed publisher
|
| Kaplonek P, Cizmeci D, Fischinger S, Collier A, SUSCOVICH T, Linde C, et al. mRNA-1273 and BNT162b2 COVID-19 vaccines elicit antibodies with differences in Fc-mediated effector functions. Sci Transl Med. 2022;14:eabm2311 pubmed publisher
|
| Boudreau C, Burke J, Shuey K, Wolf C, Katz J, Tielsch J, et al. Dissecting Fc signatures of protection in neonates following maternal influenza vaccination in a placebo-controlled trial. Cell Rep. 2022;38:110337 pubmed publisher
|
| Kaplonek P, Fischinger S, Cizmeci D, Bartsch Y, Kang J, Burke J, et al. mRNA-1273 vaccine-induced antibodies maintain Fc effector functions across SARS-CoV-2 variants of concern. Immunity. 2022;55:355-365.e4 pubmed publisher
|
| Das J, Fallon J, Yu T, Michell A, Suscovich T, Linde C, et al. Delayed fractional dosing with RTS,S/AS01 improves humoral immunity to malaria via a balance of polyfunctional NANP6- and Pf16-specific antibodies. Med. 2021;2:1269-1286.e9 pubmed publisher
|
| Herman J, Wang C, Loos C, Yoon H, Rivera J, Eugenia Dieterle M, et al. Functional convalescent plasma antibodies and pre-infusion titers shape the early severe COVID-19 immune response. Nat Commun. 2021;12:6853 pubmed publisher
|
| Chen R, Gorman M, Zhu D, Carre xf1 o J, Yuan D, Vanblargan L, et al. Reduced antibody activity against SARS-CoV-2 B.1.617.2 delta virus in serum of mRNA-vaccinated individuals receiving tumor necrosis factor-α inhibitors. Med. 2021;2:1327-1341.e4 pubmed publisher
|
| Pullen K, Atyeo C, Collier A, Gray K, Belfort M, Lauffenburger D, et al. Selective functional antibody transfer into the breastmilk after SARS-CoV-2 infection. Cell Rep. 2021;37:109959 pubmed publisher
|
| Krampert L, Bauer K, Ebner S, Neubert P, Ossner T, Weigert A, et al. High Na+ Environments Impair Phagocyte Oxidase-Dependent Antibacterial Activity of Neutrophils. Front Immunol. 2021;12:712948 pubmed publisher
|
| Gorman M, Patel N, Guebre Xabier M, Zhu A, Atyeo C, Pullen K, et al. Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccination. Cell Rep Med. 2021;2:100405 pubmed publisher
|
| Williamson L, Reeder K, Bailey K, Tran M, Roy V, Fouch M, et al. Therapeutic alphavirus cross-reactive E1 human antibodies inhibit viral egress. Cell. 2021;184:4430-4446.e22 pubmed publisher
|
| Grace P, Dolatshahi S, Lu L, Cain A, Palmieri F, Petrone L, et al. Antibody Subclass and Glycosylation Shift Following Effective TB Treatment. Front Immunol. 2021;12:679973 pubmed publisher
|
| Minassian A, Silk S, Barrett J, Nielsen C, Miura K, Diouf A, et al. Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination. Med (N Y). 2021;2:701-719.e19 pubmed publisher
|
| Jundi B, Lee D, Jeon H, Duvall M, Nijmeh J, Abdulnour R, et al. Inflammation resolution circuits are uncoupled in acute sepsis and correlate with clinical severity. JCI Insight. 2021;6: pubmed publisher
|
| Rossignol E, Dugast A, Compere H, Cottrell C, Copps J, Lin S, et al. Mining HIV controllers for broad and functional antibodies to recognize and eliminate HIV-infected cells. Cell Rep. 2021;35:109167 pubmed publisher
|
| Gunn B, Lu R, Slein M, Ilinykh P, Huang K, Atyeo C, et al. A Fc engineering approach to define functional humoral correlates of immunity against Ebola virus. Immunity. 2021;54:815-828.e5 pubmed publisher
|
| Cadena A, Ventura J, Abbink P, Borducchi E, Tuyishime H, Mercado N, et al. Persistence of viral RNA in lymph nodes in ART-suppressed SIV/SHIV-infected Rhesus Macaques. Nat Commun. 2021;12:1474 pubmed publisher
|
| Bartsch Y, Fischinger S, Siddiqui S, Chen Z, Yu J, Gebre M, et al. Discrete SARS-CoV-2 antibody titers track with functional humoral stability. Nat Commun. 2021;12:1018 pubmed publisher
|
| Atyeo C, Pullen K, Bordt E, Fischinger S, Burke J, Michell A, et al. Compromised SARS-CoV-2-specific placental antibody transfer. Cell. 2021;184:628-642.e10 pubmed publisher
|
| Atyeo C, Slein M, Fischinger S, Burke J, Sch xe4 fer A, Leist S, et al. Dissecting strategies to tune the therapeutic potential of SARS-CoV-2-specific monoclonal antibody CR3022. JCI Insight. 2021;6: pubmed publisher
|
| Barrett J, Belij Rammerstorfer S, Dold C, Ewer K, Folegatti P, Gilbride C, et al. Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses. Nat Med. 2021;27:279-288 pubmed publisher
|
| Offersen R, Yu W, Scully E, Julg B, Euler Z, Sadanand S, et al. HIV Antibody Fc N-Linked Glycosylation Is Associated with Viral Rebound. Cell Rep. 2020;33:108502 pubmed publisher
|
| Alter G, Yu W, Chandrashekar A, Borducchi E, Ghneim K, Sharma A, et al. Passive Transfer of Vaccine-Elicited Antibodies Protects against SIV in Rhesus Macaques. Cell. 2020;183:185-196.e14 pubmed publisher
|
| Om K, Paquin Proulx D, Montero M, Peachman K, Shen X, Wieczorek L, et al. Adjuvanted HIV-1 vaccine promotes antibody-dependent phagocytic responses and protects against heterologous SHIV challenge. PLoS Pathog. 2020;16:e1008764 pubmed publisher
|
| HUBBARD J, Pyzik M, Rath T, Kozicky L, Sand K, Gandhi A, et al. FcRn is a CD32a coreceptor that determines susceptibility to IgG immune complex-driven autoimmunity. J Exp Med. 2020;217: pubmed publisher
|
| Kwok I, Becht E, Xia Y, Ng M, Teh Y, Tan L, et al. Combinatorial Single-Cell Analyses of Granulocyte-Monocyte Progenitor Heterogeneity Reveals an Early Uni-potent Neutrophil Progenitor. Immunity. 2020;: pubmed publisher
|
| Gilchuk P, Murin C, Milligan J, Cross R, Mire C, Ilinykh P, et al. Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus Neutralization. Immunity. 2020;52:388-403.e12 pubmed publisher
|
| Boudreau C, Yu W, Suscovich T, Talbot H, Edwards K, Alter G. Selective induction of antibody effector functional responses using MF59-adjuvanted vaccination. J Clin Invest. 2020;130:662-672 pubmed publisher
|
| Jennewein M, Goldfarb I, Dolatshahi S, Cosgrove C, Noelette F, Krykbaeva M, et al. Fc Glycan-Mediated Regulation of Placental Antibody Transfer. Cell. 2019;: pubmed publisher
|
| Spolski R, West E, Li P, Veenbergen S, Yung S, Kazemian M, et al. IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus. elife. 2019;8: pubmed publisher
|
| Bornholdt Z, Herbert A, Mire C, He S, Cross R, Wec A, et al. A Two-Antibody Pan-Ebolavirus Cocktail Confers Broad Therapeutic Protection in Ferrets and Nonhuman Primates. Cell Host Microbe. 2019;25:49-58.e5 pubmed publisher
|
| Ilinykh P, Santos R, Gunn B, Kuzmina N, Shen X, Huang K, et al. Asymmetric antiviral effects of ebolavirus antibodies targeting glycoprotein stem and glycan cap. PLoS Pathog. 2018;14:e1007204 pubmed publisher
|
| Gunn B, Yu W, Karim M, Brannan J, Herbert A, Wec A, et al. A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus. Cell Host Microbe. 2018;24:221-233.e5 pubmed publisher
|
| Gilchuk P, Kuzmina N, Ilinykh P, Huang K, Gunn B, Bryan A, et al. Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein. Immunity. 2018;49:363-374.e10 pubmed publisher
|
| Luke T, Bennett R, Gerhardt D, Burdette T, Postnikova E, Mazur S, et al. Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate. J Infect Dis. 2018;218:S636-S648 pubmed publisher
|
| King L, Fusco M, Flyak A, Ilinykh P, Huang K, Gunn B, et al. The Marburgvirus-Neutralizing Human Monoclonal Antibody MR191 Targets a Conserved Site to Block Virus Receptor Binding. Cell Host Microbe. 2018;23:101-109.e4 pubmed publisher
|
| Alcántara Hernández M, Leylek R, Wagar L, Engleman E, Keler T, Marinkovich M, et al. High-Dimensional Phenotypic Mapping of Human Dendritic Cells Reveals Interindividual Variation and Tissue Specialization. Immunity. 2017;47:1037-1050.e6 pubmed publisher
|
| Lu L, Chung A, Rosebrock T, Ghebremichael M, Yu W, Grace P, et al. A Functional Role for Antibodies in Tuberculosis. Cell. 2016;167:433-443.e14 pubmed publisher
|
| Meinke P, Schneiderat P, Srsen V, Korfali N, Lê Thà nh P, Cowan G, et al. Abnormal proliferation and spontaneous differentiation of myoblasts from a symptomatic female carrier of X-linked Emery-Dreifuss muscular dystrophy. Neuromuscul Disord. 2015;25:127-36 pubmed publisher
|
| Norling L, Dalli J, Flower R, Serhan C, Perretti M. Resolvin D1 limits polymorphonuclear leukocyte recruitment to inflammatory loci: receptor-dependent actions. Arterioscler Thromb Vasc Biol. 2012;32:1970-8 pubmed publisher
|